Chung-Pin Li
Overview
Explore the profile of Chung-Pin Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
2984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng S, Lee H, Li C, Lin M, Chou M, Yen Y, et al.
ACS Nano
. 2024 Oct;
18(43):29439-29456.
PMID: 39405469
The stimulator of interferon genes (STING) pathway is crucial for tumor immunity, leading to the exploration of STING agonists as potential immunotherapy adjuvants. However, their clinical application faces obstacles including...
2.
Lin Y, Yang Y, Chen C, Huang C, Li C, Shen H, et al.
Med Teach
. 2024 Oct;
:1-10.
PMID: 39400116
Background: Objective structured clinical examination (OSCE) is used worldwide. This study aims to explore potential alternatives to the OSCE by using entrustable professional activities (EPA)-based assessments in the workplace. Methods:...
3.
Li C, Lee P, Huang K, Huang K, Chang T, Chang C, et al.
J Chin Med Assoc
. 2024 Sep;
87(12):1099-1100.
PMID: 39267366
No abstract available.
4.
Li C, Lee P, Huang K, Huang K, Chang T, Chang C, et al.
J Chin Med Assoc
. 2024 Jul;
87(9):819-827.
PMID: 39017659
Background: Surgical resection (SR) is the main treatment for small bowel adenocarcinoma (SBA), but it increases metabolic demand, systemic inflammation, and digestive dysfunction, resulting in major impacts on the postoperative...
5.
Lin Z, Li C, Sun C, Cho D, Tsai F, Yip H, et al.
Inflamm Bowel Dis
. 2024 Apr;
31(2):351-361.
PMID: 38567440
Background: Despite the known association between microorganisms and development of inflammatory bowel disease (IBD), the role of nontyphoidal Salmonella (NTS) in IBD is not adequately addressed. We aimed at elucidating...
6.
Tang C, Yang S, Li C, Su Y, Chiu S, Bai L, et al.
Pancreatology
. 2024 Apr;
24(4):600-607.
PMID: 38565467
Background/objectives: Liposomal irinotecan plus 5-fluorouracil and leucovorin (nal-IRI + 5-FU/LV) provides survival benefits for metastatic pancreatic adenocarcinoma (mPDAC) refractory to gemcitabine-based treatment, mainly gemcitabine plus nab-paclitaxel (GA), in current practice....
7.
Wu Y, Shen S, Wang Y, Chang N, Lee P, Li C, et al.
J Chin Med Assoc
. 2024 Mar;
87(5):511-515.
PMID: 38478012
Background: Pancreatic adenocarcinoma is often not diagnosed until an advanced stage, and so most patients are not eligible for resection. For patients who are inoperable, definitive radiotherapy is crucial for...
8.
Li H, Chiang C, Kwak K, Wang X, Doddi S, Ramanathan L, et al.
Adv Sci (Weinh)
. 2024 Jan;
11(11):e2306373.
PMID: 38204202
Detecting pancreatic duct adenocarcinoma (PDAC) in its early stages and predicting late-stage patient prognosis undergoing chemotherapy is challenging. This work shows that the activation of specific oncogenes leads to elevated...
9.
Su Y, Chiang N, Chiu T, Huang C, Hsu S, Lin H, et al.
Biomed J
. 2024 Jan;
47(3):100696.
PMID: 38169173
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Over the past decade, significant therapeutic advancements have improved the survival rates of patients with pancreatic cancer. One of...
10.
Yuan E, Huang S, Hsu C, Lirng J, Li T, Huang C, et al.
J Educ Eval Health Prof
. 2023 Dec;
20:37.
PMID: 38148494
Purpose: Coronavirus disease 2019 (COVID-19) has heavily impacted medical clinical education in Taiwan. Medical curricula have been altered to minimize exposure and limit transmission. This study investigated the effect of...